Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Landis

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Reproductive Biomedicine Online|March 26, 2016
FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cyclesScott J Morin, Ashley W Tiegs, Jason M Franasiak, et al.
Biology of Reproduction|February 26, 2016
Next Generation Sequencing-Based Comprehensive Chromosome Screening in Mouse Polar Bodies, Oocytes, and EmbryosNathan R Treff, Rebecca L Krisher, Xin Tao, et al.
RMD Open|May 21, 2026
Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitisWalter P Maksymowych, Anusha Yeshokumar, Elizabeth Cerullo, et al.
The Lancet. Rheumatology|May 4, 2026
Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled studyMikkel Østergaard, Espen A Haavardsholm, Miroslawa Nowak, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Reproductive Biomedicine Online|March 26, 2016
FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cyclesScott J Morin, Ashley W Tiegs, Jason M Franasiak, et al.
Biology of Reproduction|February 26, 2016
Next Generation Sequencing-Based Comprehensive Chromosome Screening in Mouse Polar Bodies, Oocytes, and EmbryosNathan R Treff, Rebecca L Krisher, Xin Tao, et al.
RMD Open|May 21, 2026
Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitisWalter P Maksymowych, Anusha Yeshokumar, Elizabeth Cerullo, et al.
The Lancet. Rheumatology|May 4, 2026
Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled studyMikkel Østergaard, Espen A Haavardsholm, Miroslawa Nowak, et al.
Pageof 2